Flagship Pioneering’s ProFound Therapeutics is keeping its string of high-profile partnerships going, forging a new pact with the Gates Foundation worth up to $35 million to find new drug targets for a dangerous pregnancy complication.
Morbi et tellus imperdiet, aliquam nulla sed, dapibus erat. Aenean dapibus sem non purus venenatis vulputate. Donec accumsan eleifend blandit. Nullam auctor ligula
Flagship Pioneering’s ProFound Therapeutics is keeping its string of high-profile partnerships going, forging a new pact with the Gates Foundation worth up to $35 million to find new drug targets for a dangerous pregnancy complication.